A new market study, titled “Global Alzheimer’s Disease Diagnostic Market Research Report- Forecast to 2022” has been featured on WiseGuyReports.
This report analyzes the global alzheimer’s disease diagnostic market by type (early-onset alzheimer’s, late-onset alzheimer’s, familial alzheimer’s disease), by diagnostic test (genetic testing, neurological exam, mini-mental state exam (MMSE), brain imaging and others), by end users (clinics, hospitals, diagnostic centers and others); it also studies the top manufacturers in the market.
The global alzheimer’s disease diagnostic market is projected to reach USD 12 billion, at a CAGR of 10% by the end of the forecasted period.
The major players in global alzheimer’s disease diagnostic market include:
- Eli Lilly and Company (UK)
- TauRx (Republic of Singapore)
- Alector LLC (US)
- Accera, Inc. (US)
- Treventis Corporation (US)
- Neuro-Bio Ltd (UK)
- Cognition Therapeutics Inc. (US)
The market revenue and share have been analyzed with respect to the following regions and countries:
Rest of Europe
Republic of Korea
Rest of Asia-Pacific
Middle East & Africa
On the basis of type, the global alzheimer’s disease diagnostic market has been categorized into the following segments:
- Early-onset Alzheimer’s
- Late-onset Alzheimer’s
- Familial Alzheimer’s disease
On the basis of diagnostic test, the global alzheimer’s disease diagnostic market has been categorized into the following segments:
- Genetic testing
- Neurological exam
- Mini-mental state exam (MMSE)
- Brain imaging and others
On the basis of end users, the global alzheimer’s disease diagnostic market has been categorized into the following segments:
- Diagnostic Centers
The analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis added before being presented in this report.
Table of Content
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Alzheimer’s Disease Diagnostic Market, By Type
6 Global Alzheimer’s Disease Diagnostic Market, By Diagnostic Tests
7 Global Alzheimer’s Disease Diagnostic Market, By End Users
8 Global Alzheimer’s Disease Diagnostic Market, By Regions
9 Company Landscape
10 Company Profile
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)